Fact CheckerSign in

NCT07876453Completed

Feasibility and Preliminary Outcomes of Compassion-Focused Group Therapy for Depression and Anxiety

Investigation of Loneliness and Its Associations With Emotion Regulation, Lifestyle Habits, Mental Health Problems, and Psychotherapeutic Treatment Outcomes, Substudy 5: Compassion-Focused Therapy (CFT) for Depression and Anxiety Disorders

Source: ClinicalTrials.gov · Last updated 21 Oct 2026

Brief summary (registry, in English)

This pilot study evaluated the feasibility and preliminary outcomes of compassion-focused group therapy (CFT) for adults with depression and/or anxiety who continued to experience symptoms despite previous treatment. CFT aims to help individuals develop a more compassionate attitude toward themselves and reduce self-criticism and shame, which may contribute to psychological distress. The study was conducted at a specialized psychiatric outpatient clinic in Stockholm, Sweden, during 2023-2024. A total of 21 participants received an 11-week group treatment consisting of weekly group sessions and brief individual telephone consultations. The study examined whether participants were willing and able to complete the treatment and whether the treatment was acceptable and feasible in routine psychiatric care. Changes in self-compassion, depressive symptoms, difficulties in emotion regulation, social safeness, everyday functioning, and quality of life were assessed before treatment, immediately after treatment, and three months later. The findings were intended to inform the further development and evaluation of compassion-focused group therapy for patients with persistent depression and anxiety symptoms.

Status (registry)
Completed
Study type
Interventional
Enrollment
21 (actual)
First submitted
9 Oct 2026
Start date
1 Jul 2023
Primary completion date
8 Apr 2024
Lead sponsor
Karolinska Institutet
Diseases
Depression
NCT number
NCT07876453

What you commit to

  • Study type: Interventional
  • Participants enrolled: 21
  • From 1 Jul 2023 to the primary completion date, 8 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Acute physical or psychiatric conditions requiring immediate hospital care, such as severe underweight or an acute suicidal crisis.

Other

  • Inability to independently complete self-report questionnaires due to cognitive difficulties and/or insufficient Swedish language proficiency.
  • Practical or scheduling difficulties preventing participation in group treatment.

Who the study is looking for

  • Age 18 years or older.
  • Previously completed at least one pharmacological or psychological treatment consistent with Swedish national treatment guidelines for depression and/or anxiety disorders.
  • Moderate to severe symptoms of depression and/or anxiety.
  • Self-reported difficulties related to self-criticism or shame during the initial assessment.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sollentuna Psychiatric Outpatient Clinic, Psychiatry Northwest (Psykiatri Nordväst)
Coordinator of this site? Confirm its status
StockholmSwedenUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.